A new round of Congressional legislation targets China. Will they pass? And when they do, will the government take action, or issue endless reviews and investigations as China marches on, and America risks stalling out post-pandemic.
Yellen takes a pass on calling Vietnam, others, currency manipulators. That puts the onus on Commerce and the USTR to do something about it. Will they?
Worried about climate change, Senator Wyden and the Democrats want to give cleantech and energy companies permanent tax breaks. He faces some serious opposition.
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
From retail investors in China ETFs, to Wall Street’s largest investment firms, China’s new technologies can always count on tens of millions of dollars of inflows from Americans. What do we get in return?
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
The trend continues. A Chinese couple indicted over biotech trade secret’s lifted from Ohio research hospital.
Striking all the right chords and buzzwords, China leader Xi Jinping says what the world needs now is love sweet love. Who’s buying?
A look at the destructive pricing pressures on American cattle ranchers, and the minority and tribal groups that depend on them. Are we outsourcing cattle ranching in the name of climate change?
For Katherine Tai and the Biden administration, environmentalism is going to be the core of trade policy. How does that square with heavy polluters like India and China?
